CasImg
喹吖因二盐酸
产品纠错
CAS号:69-05-6 | 英文名称:Quinacrine (dihydrochloride)
分子式 C23H32Cl3N3O
分子量 473
EINECS号 200-700-8
MDL MFCD00012659
Smiles
InChIKey
乙二醇化学百科
基本信息
中文名称 二盐酸奎吖因水合物
英文名称 QUINACRINE DIHYDROCHLORIDE
CAS号 69-05-6
分子式 C23H32Cl3N3O
分子量 472.88
EINECS号 200-700-8
物化性质
熔点 249-251℃ (Decomposition)
密度 1.2962 (rough estimate)
折射率 1.6300 (estimate)
溶解度 可溶于DMSO(轻微)、甲醇(轻微、超声处理)、水(轻微)
形态 黄色固体
酸度系数(pKa) pKa -6.3(H2Ot undefinedI not reportedbut low) (Uncertain)
颜色 浅黄色至厚黄色
PH值 3.0~5.0 (20g/l, 25℃)
水溶解性 Water: 33.33 mg/mL (70.48 mM)
Merck 14,8044
BRN 4834013
稳定性 稳定的。与强氧化剂不相容。
安全信息
危险品标志 Xn
危险类别码 22-36/37/38
安全说明 36/37/39
WGK Germany 3
RTECS号 AR7875000
毒性 LD50 oral in rabbit: 433mg/kg
生产及用途
Quinacrine 2HCl是具有多种作用的亲脂性阳离子药物,通常用作抗原生动物剂。Quinacrine是有效的phospholipase A2抑制剂。
TargetValue
PLA2
()

Quinacrine (5-20 μM; 24 hours) inhibits the growth of SGC-7901 cells.
Quinacrine (7.5 and 15 μM; 24 hours) induces apoptosis in SGC-7901 cells, which is associated with mitochondria-dependent signal pathway and involves p53 upregulation and caspase-3 activation pathway.
Quinacrine (15 μM; 24 hours) treatment significantly increased the levels of proapoptotic proteins, including cytochrome c, Bax, and p53, and decreased the levels of antiapoptotic protein Bcl-2, thus shifting the ratio of Bax/Bcl-2 in favor of apoptosis .

Cell Viability Assay

Cell Line: SGC-7901 cells
Concentration: 0, 5, 10, 15, and 20 μM
Incubation Time: 24 hours
Result: Cell viability was inhibited in a dose-dependent manner, and the mean IC 50 value is 16.18 μM.

Apoptosis Analysis

Cell Line: SGC-7901 cells
Concentration: 7.5 and 15 μM
Incubation Time: 24 hours
Result: The percentage of apoptotic cells, including the early phase and late phase apoptosis, increased to 26.30%, compared with control group of 3.37%.

Western Blot Analysis

Cell Line: SGC-7901 cells
Concentration: 15 μM
Incubation Time: 24 hours
Result: The relative quantity of cytochrome c protein was upregulated, increased from 0.10 to 0.24.
The relative quantity of p53 protein was dramatically increased, from 0.06 to 0.19.
The Bax/Bcl-2 ratio was dramatically elevated from 1.21 to 2.59.

Quinacrine (100 mg/kg three times per week for two consecutive weeks) significantly suppresses circulating blast cells at days 30/31 and increases the median survival time (MST). Quinacrine does not decrease the body weight of treated animals at the tested dose.

Animal Model: Female SCID mice with acute myeloid leukemia (AML)-PS model
Dosage: 100 mg/kg
Administration: Administered by oral gavage (po); three times a week for two consecutive weeks
Result: In the first AML mouse in vivo study, evaluation of circulating leukemic cells detected in blood samples (in percent of white blood cells (WBC)) at day 30/31 showed 72% human tumor cells in the control mice, whereas in mice treated with Quinacrine, this was only 2.2%.
The MST of control mice was 34 days whereas it was 46 days in Quinacrine-treated mice.
类别
有毒物质
毒性分级
中毒
急性毒性
口服- 大鼠 LD50: 660 毫克/ 公斤; 口服- 小鼠 LD50: 557 毫克/ 公斤
可燃性危险特性
可燃;火场释放有毒氮氧化物, 氯化物烟雾
储运特性
库房低温, 通风, 干燥
灭火剂
水, 二氧化碳, 泡沫, 沙土
上下游产品
上游产品共计:0个
下游产品共计:0个
产品供应商
Quinacrine dihydrochloride
询价
上海阿拉丁生化科技股份有限公司
2023-10-02

首页 |  CAS目录 |  产品目录 |  企业会员 |  关于我们 |  法律声明 |  注册协议

Copyright © 冀ICP备2024096099号